Sebastien Latapie has been working at the intersection of healthcare and technology as a researcher, consultant, and investors for over 8 years. At Dynamk, he is involved in all aspects of deal sourcing, diligence, and is a board observer at 4 of Dynamk’s portfolio companies.

Sebastien has a B.S. in Microbiology and Immunology and Master’s in Biochemistry from McGill University as well as an MBA from Columbia Business School.